UVA IDs Heart Drug by Combining Machine Learning, Human Learning

UVA IDs Heart Drug by Combining Machine Learning, Human Learning

Scientists have developed a new approach to machine learning – a form of AI – to identify drugs that help minimize harmful heart scarring.

UVA Health Newsroom

UVA Cancer Center Enrolls First Patient in National Phase 1 Immunotherapy Trial - Medicine in Motion News

UVA Cancer Center Enrolls First Patient in National Phase 1 Immunotherapy Trial

Led by Associate Professor of Hematology and Oncology Matthew Reilley, MD, the UVA Comprehensive Cancer Center (UVACCC) recently enrolled the first patient in a nationwide Phase 1 drug trial to evaluate a new immunotherapy drug’s potential to treat...

Medicine in Motion News

Get to Know Colin Derdeyn, MD — Chair of Radiology and Medical Imaging - Medicine in Motion News

Get to Know Colin Derdeyn, MD — Chair of Radiology and Medical Imaging

Colin Derdeyn, MD, joined UVA Department of Radiology and Medical Imaging, effective January 2, 2024. Dr. Derdeyn is a renowned physician scientist and national leader in improving stroke care of patients across the country. He joined UVA from the Un...

Medicine in Motion News

The Relationship Between Y Chromosome Loss & Heart Failure

UVA Health Research Reveals Causal Relationship Between Y Chromosome Loss & Heart Failure

UVA Health-led research reveals a major reason why men age faster and how cardiologists could decrease this disparity with antifibrotics.

Healthy Practice

Research In Motion: Wendy Lynch, PhD - Research - Medicine in Motion News

Research In Motion: Wendy Lynch, PhD

I study the neurobiology of addiction. Looking at how the brain changes once addiction has developed, I use preclinical models to look at these changes in the brains, including both males and females in my studies, so I can look at the sex difference...

Medicine in Motion News